Oruka Therapeutics (ORKA) Shares Outstanding (2010 - 2026)

Oruka Therapeutics has reported Shares Outstanding for 17 years, with the latest figure at $50.2 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 36481.85% year-over-year to $50.2 million; the trailing twelve-month figure through Mar 2026 stood at $50.2 million (up 36481.85% YoY), and the FY2025 full-year result was $48.7 million, up 30.13% from the prior year.
• Shares Outstanding for Q1 2026 stood at $50.2 million, up from $48.7 million in the prior quarter.
• The five-year high for Shares Outstanding was $50.2 million in Q1 2026, with the low at $14.4 million in Q1 2022.
• Average Shares Outstanding over 5 years is $26.5 million, with a median of $20.0 million recorded in 2024.
• Year-over-year, Shares Outstanding sank 99.31% in 2025 and jumped 36481.85% in 2026.
• Tracing ORKA's Shares Outstanding over 5 years: stood at $14.4 million in 2022, then gained by 0.63% to $14.5 million in 2023, then soared by 158.19% to $37.4 million in 2024, then soared by 30.13% to $48.7 million in 2025, then gained by 2.97% to $50.2 million in 2026.
• The last three Shares Outstanding figures came in at $50.2 million (Q1 2026), $48.7 million (Q4 2025), and $48.4 million (Q3 2025), per Business Quant data.

Peer Comparison